Kephera Diagnostics awarded contract from the National Cancer Institute for development of a test for parasite linked to a rare cancer

Sep 26, 2019

Posted by Kephera Diagnostics

The Race to EU MDR Compliance Continues

Sep 25, 2019

Posted by KPMG LLP

Confronting the Challenges of Rare Disease

Sep 25, 2019

Standardizing and Linking Diverse Registry and Other Real-World Observational Data Yields Enhanced Understanding of Rare Diseases and Their Treatments

Sep 25, 2019

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash

Sep 25, 2019

Posted by Cambrex

BioIVT Joins Medicines Discovery Catapult’s Discovery Services Platform to Support Drug Discovery in the UK

Sep 24, 2019

Posted by BioIVT

InveniAI Launches Suite of Products Powered by AlphaMeld™, an Artificial Intelligence Platform, to Enable Robust Decision Making for Multiple Stakeholders in the Life Sciences

Sep 17, 2019

Cybrexa Therapeutics Closes $13.4M in Series B1 Funding Round

Sep 13, 2019

LaVoieHealthScience Looks to the Future, Promotes Sharon Correia and Ella Deych

Sep 12, 2019